Michiko Taniguchi
About
In The Last Decade
Michiko Taniguchi
16 papers receiving 418 citations
Peers
Comparison fields: 5 of 47
- Transplantation 193
- Surgery 176
- Epidemiology 132
- Hepatology 118
- Immunology 116
Countries citing papers authored by Michiko Taniguchi
This map shows the geographic impact of Michiko Taniguchi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michiko Taniguchi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michiko Taniguchi more than expected).
Fields of papers citing papers by Michiko Taniguchi
This network shows the impact of papers produced by Michiko Taniguchi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michiko Taniguchi. The network helps show where Michiko Taniguchi may publish in the future.
Co-authorship network of co-authors of Michiko Taniguchi
This figure shows the co-authorship network connecting the top 25 collaborators of Michiko Taniguchi. A scholar is included among the top collaborators of Michiko Taniguchi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michiko Taniguchi. Michiko Taniguchi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 1 | |
| 3 | 34 | |
| 4 | 2 | |
| 5 | 1 | |
| 6 | 1 | |
| 7 | 3 | |
| 8 | Risk Stratification of Human Leukocyte Antigen Class II Donor Specific Antibody Positive Patients by Immunoglobulin G Subclasses. | 5 |
| 9 | 60 | |
| 10 | 100 | |
| 11 | 17 | |
| 12 | Liver transplantation in the MELD era--analysis of the OPTN/UNOS registry. | 36 |
| 13 | 35 | |
| 14 | 21 | |
| 15 | 107 | |
| 16 | A Potent Osmoregulant,Dimethylsulfoniopropionate,in Anaaosa | 1 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.